Forecast: Child Immunization Coverage Against BCG in Singapore

The child immunization coverage against BCG in Singapore has exhibited remarkable stability over the past decade, consistently maintaining a high coverage rate of 98-99%. As of 2023, the coverage stood at 98% among 1-year-old children. Although there was a slight decline from 99% to 98% in 2018, the year-on-year variation has been negligible, with a CAGR of -0.2% over the last five years.

Looking ahead to the forecasted data from 2024 to 2028, the child immunization rate is expected to remain steady at 98%, reflecting no significant changes or growth rate.

Future trends to watch for:

- Potential changes in immunization policies or public health campaigns could influence coverage rates.- Monitoring the emergence of new vaccine protocols and their adoption rates.- Consideration of any socioeconomic factors that may affect vaccine accessibility and coverage.

Latest reports

 US Vaccine Market Report- Q1 2025

US Vaccine Market Report- Q1 2025

The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...

 China Vaccine Market Report- Q1 2025

China Vaccine Market Report- Q1 2025

The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...

 Japan Vaccine Market Report- Q4 2024

Japan Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...

 Germany Vaccine Market Report- Q4 2024

Germany Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...

 India Vaccine Market Report- Q4 2024

India Vaccine Market Report- Q4 2024

The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...

 UK Vaccine Market Report- Q4 2024

UK Vaccine Market Report- Q4 2024

The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...

 France Vaccine Market Report- Q4 2024

France Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...

 Canada Vaccine Market Report- Q4 2024

Canada Vaccine Market Report- Q4 2024

The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...

 Brazil Vaccine Market Report- Q4 2024

Brazil Vaccine Market Report- Q4 2024

The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...

 Italy Vaccine Market Report- Q4 2024

Italy Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...

Top Countries about mRNA Vaccine